Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTALKINECP: Ibuprofen vs placebo for physiotherapy-related pain in children with cerebral palsy
2015-005538-23Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in cerebral palsy (CP) (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Reduction in physiotherapy-related pain on VAS. Started Mar 2016; status: completed.
02
Drugs
ibuprofen
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on 2015-005538-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005538-23.